𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The renal excretion of xanthurenic acid following L-tryptophan loading in depressed patients

✍ Scribed by M. Maes; M. De Ruyter; E. Suy


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
414 KB
Volume
2
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis


Xanthurenic acid (XA) is a secondary product of the biosynthesis of nicotinamide from L-tryptophan. Disturbances in this pathway have been observed in depression. An enhanced glucocorticoid secretion is considered to induce this pathway. This could result in reduced levels of L-tryptophan (L-TRP) in the plasma. The present study investigates whether the synthesis of X A from L-TRP is disturbed in depression, and also whether the synthesis of X A is intercorrelated with L-TRP or measures of glucocorticoid secretion. To this end the XA excretion in 24 hour urine following L-TRP loading was determined in 166 psychiatric inpatients. There were no significant differences in X A excretion between non-depressed psychiatric controls, minor depression and major depression. Among the depressed patients there was a significant (p < 0.01) negative correlation between the excretion of XA and total L-TRP levels in plasma, with abnormally decreased (p < 0.0006) L-TRP levels occurring in the depressed patients with a disturbed X A excretion (3 106.8 pmo1/24 hour).


πŸ“œ SIMILAR VOLUMES


The clinical significance of disordered
✍ M. J. A. J. M. Hoes; N. Sijben πŸ“‚ Article πŸ“… 1981 πŸ› Springer 🌐 English βš– 458 KB

Xanthurenic acid is a metabolite of L-tryptophannicotinic acid ribonucleotide biosynthesis. The excretion of xanthurenic acid from urine 24 h after ingestion of 5 g L-tryptophan is increased in depressive patients, and 17-hydroxycorticosteroids are considered of primary importance to this disorder.

Special considerations with regard to th
✍ Andersson, L. ;Eriksson, O. ;Hedlund, P.-O. ;Kjellman, H. ;Lindqvist, B. πŸ“‚ Article πŸ“… 1978 πŸ› Springer 🌐 English βš– 368 KB

Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions. Since it is eliminated mainly in the urine, the drug accumulates in patients with uraemia. The excretion of tranexamic acid in patients with renal failure h